Start Date
May 31, 2000
Primary Completion Date
August 31, 2005
pegylated liposomal doxorubicin hydrochloride
Duke Comprehensive Cancer Center, Durham
Brookview Research, Inc., Nashville
Washington University School of Medicine, St Louis
Chao Family Comprehensive Cancer Center, Orange
Indiana University Cancer Center, Indianapolis
Holden Comprehensive Cancer Center, Iowa City
New England Medical Center Hospital, Boston
University of Mississippi Medical Center, Jackson
Comprehensive Cancer Center at Wake Forest University, Winston-Salem
Arthur G. James Cancer Hospital - Ohio State University, Columbus
National Cancer Institute (NCI)
NIH
Gynecologic Oncology Group
NETWORK